Nitric_JJ
oxide_NN
decreases_VBZ
cytokine-induced_JJ
endothelial_JJ
activation_NN
._.

Nitric_JJ
oxide_NN
selectively_RB
reduces_VBZ
endothelial_JJ
expression_NN
of_IN
adhesion_NN
molecules_NNS
and_CC
proinflammatory_JJ
cytokines_NNS
._.

To_TO
test_VB
the_DT
hypothesis_NN
that_IN
nitric_JJ
oxide_NN
-LRB-_-LRB-
NO_NN
-RRB-_-RRB-
limits_VBZ
endothelial_JJ
activation_NN
,_,
we_PRP
treated_VBD
cytokine-stimulated_JJ
human_JJ
saphenous_JJ
vein_NN
endothelial_JJ
cells_NNS
with_IN
several_JJ
NO_NN
donors_NNS
and_CC
assessed_VBD
their_PRP$
effects_NNS
on_IN
the_DT
inducible_JJ
expression_NN
of_IN
vascular_JJ
cell_NN
adhesion_NN
molecule-1_NN
-LRB-_-LRB-
VCAM-1_NN
-RRB-_-RRB-
._.

In_IN
a_DT
concentration-dependent_JJ
manner_NN
,_,
NO_NN
inhibited_VBD
interleukin_NN
-LRB-_-LRB-
IL_NN
-RRB-_-RRB-
-1_CD
alpha-stimulated_JJ
VCAM-1_NN
expression_NN
by_IN
35-55_CD
%_NN
as_IN
determined_VBN
by_IN
cell_NN
surface_NN
enzyme_NN
immunoassays_NNS
and_CC
flow_NN
cytometry_NN
._.

This_DT
inhibition_NN
was_VBD
paralleled_VBN
by_IN
reduced_VBN
monocyte_NN
adhesion_NN
to_TO
endothelial_JJ
monolayers_NNS
in_IN
nonstatic_JJ
assays_NNS
,_,
was_VBD
unaffected_JJ
by_IN
cGMP_NN
analogs_NNS
,_,
and_CC
was_VBD
quantitatively_RB
similar_JJ
after_IN
stimulation_NN
by_IN
either_CC
IL-1_NN
alpha_NN
,_,
IL-1_NN
beta_NN
,_,
IL-4_NN
,_,
tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
alpha_NN
-RRB-_-RRB-
,_,
or_CC
bacterial_JJ
lipopolysaccharide_NN
._.

NO_NN
also_RB
decreased_VBD
the_DT
endothelial_JJ
expression_NN
of_IN
other_JJ
leukocyte_NN
adhesion_NN
molecules_NNS
-LRB-_-LRB-
E-selectin_NN
and_CC
to_TO
a_DT
lesser_JJR
extent_NN
,_,
intercellular_JJ
adhesion_NN
molecule-1_NN
-RRB-_-RRB-
and_CC
secretable_JJ
cytokines_NNS
-LRB-_-LRB-
IL-6_NN
and_CC
IL-8_NN
-RRB-_-RRB-
._.

Inhibition_NN
of_IN
endogenous_JJ
NO_NN
production_NN
by_IN
L-N-monomethyl-arginine_NN
also_RB
induced_VBD
the_DT
expression_NN
of_IN
VCAM-1_NN
,_,
but_CC
did_VBD
not_RB
augment_VB
cytokine-induced_JJ
VCAM-1_NN
expression_NN
._.

Nuclear_JJ
run-on_JJ
assays_NNS
,_,
transfection_NN
studies_NNS
using_VBG
various_JJ
VCAM-1_NN
promoter_NN
reporter_NN
gene_NN
constructs_NNS
,_,
and_CC
electrophoretic_JJ
mobility_NN
shift_VB
assays_NNS
indicated_VBD
that_IN
NO_NN
represses_VBZ
VCAM-1_NN
gene_NN
transcription_NN
,_,
in_IN
part_NN
,_,
by_IN
inhibiting_VBG
NF-kappa_NN
B_NN
._.

We_PRP
propose_VBP
that_IN
NO_NN
's_POS
ability_NN
to_TO
limit_VB
endothelial_JJ
activation_NN
and_CC
inhibit_VB
monocyte_NN
adhesion_NN
may_MD
contribute_VB
to_TO
some_DT
of_IN
its_PRP$
antiatherogenic_JJ
and_CC
antiinflammatory_JJ
properties_NNS
within_IN
the_DT
vessel_NN
wall_NN
._.

